<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000346487"><TermName>anakinra</TermName><TermPronunciation>(A-nuh-KIN-ruh)</TermPronunciation><TermDefinition><DefinitionText>A substance that is used to treat rheumatoid arthritis, and is being studied in the treatment of cancer. Anakinra blocks the action of interleukin 1 (IL-1). It is a type of interleukin receptor antagonist. Also called Kinaret.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000711564" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anakinra&quot;" language="en" id="_3"/><MediaLink ref="CDR0000711563" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anakinra&quot;" language="es" id="_4"/><SpanishTermName>anakinra</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia que se usa para tratar la artritis reumatoide y que está en estudio para el tratamiento de cáncer. La anakinra bloquea la acción de la interleucina 1 (IL-1). Es un tipo de antagonista del receptor de interleucina. También se llama Kinaret.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-11-20</DateFirstPublished><DateLastModified>2007-01-18</DateLastModified></GlossaryTerm>
